Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × Transurethral Resection of Prostate × Clear all

NCT05240404 2022-02-15

Adjuvant Immunotherapy With Toripalimab Following Curative-intent Ablation for Recurrent Hepatocarcinoma

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular